Site Map

8-section, 63-item assessment for acute care, inpatient, and surgical settings

7-section, 45-item assessment for retail pharmacy and outpatient dispensing settings

Per-site checklists with consolidated scoring across multiple facilities

Settlements, civil penalties and criminal fines paid by hospitals and pharmacies in documented drug diversion cases, with the amount, year and primary source for each

Counts of the outcomes the registry records state: prison, probation, fines, licence actions and restitution, with stated sentence lengths by band and by drug class

Sentence lengths, fines and restitution, cases per 100,000 pharmacists by state, and plea and licence outcomes, each counted from the case records with its n, plus charts of cases by year, state and drug class

Charts and data tables from 931 documented federal and state cases — drugs, settings, outcomes, and cases by year

A free PDF making the case for a diversion prevention program — documented penalties, deaths and how to evidence your own value, every figure cited

Step-by-step guide from initial report through resolution and corrective action

Ready-to-adapt diversion prevention, waste witnessing, POM, and camera policies

New hire awareness, annual competency, red flag recognition, and waste documentation

DEA requirements, state board obligations, PDMP mandates, and Joint Commission standards

Every controlled substance record a pharmacy or hospital must keep under 21 CFR Parts 1304, 1305 and 1317, with the section each comes from and what to have ready for an inspection

What people-driven counts and reconciliations catch, what cabinet analytics and peer scoring catch, where each is blind, and how to combine them by setting

Risk profiles for ED, ICU, OR, Med-Surg, Oncology, and Pharmacy departments

Preparation, questioning techniques, documentation standards, and legal considerations

When to file, step-by-step form completion, common mistakes, and sample scenarios

KPIs, benchmarks, sample SQL, and Power BI/Tableau layout blueprint for surveillance

What monitoring, detection, surveillance, and auditing software actually do, the real categories of tooling, what the data can and can't prove, and how to evaluate a vendor

ETL, data model, DAX measures, and dashboard design for controlled substance surveillance

Tailored messaging for anesthesia, nursing, pharmacy, and executive leadership

Behavioral, documentation, and inventory warning signs your staff should know

Pre-employment vetting, DEA screening requirements, and ongoing fitness-for-duty monitoring for staff with controlled substance access

When and how to notify patients potentially exposed through drug diversion, with bloodborne pathogen testing guidance

Copy-paste AI prompts for ChatGPT, Claude, Gemini, and Copilot to detect waste, overrides, discrepancies, and off-hours access

Where a clinician starts: what to ask IT, what to do when IT says no, which data you already have, which AI capabilities matter, realistic timelines, and how to validate without exposing PHI

Daily practical insights for pharmacy diversion prevention programs — controls to check, patterns to watch, and compliance questions to ask.

Which controlled substances appear most often in federal cases, with audit red flags and linked case examples for each drug

What's trending up in healthcare drug diversion, tracked from recent DEA/DOJ enforcement news

What a hospital drug diversion prevention program needs — oversight, surveillance, waste controls, investigation — and the questions to ask about each.

Prepare for a DEA inspection: inventory, Form 222 and CSOS orders, Form 106 loss reports, Form 41 destruction and renewals.

What a community pharmacy should review to catch controlled substance diversion: staff access, counts, returns and prescriptions.

Where controlled substance diversion hides in sterile, nonsterile and hazardous-drug compounding, and the access, waste and logging controls that close it.

How to audit a controlled substance program for diversion: what to test from ordering to waste, how often, and who should do it.

What DEA actually requires (an inventory every two years, accurate records, no perpetual inventory) and where shift and daily count intervals really come from.

Reports owed when an employee diverts controlled substances: fixed federal DEA deadlines, plus board and state duties that vary by state and profession.

What federal rules require of a hospital or pharmacy to guard against diversion, what is left to state and accreditor, and when a written program is required.

Diversion warning signs for opioids, benzodiazepines, stimulants, propofol and ketamine, and controlled drugs in long-term care, with the rules for each.

High-risk scenarios with annotated SQL: PCA, multidose vials, overrides, waste lag

Placement guides, retention requirements, OR strategy, and maintenance schedule

A checked directory of federal guidance, state board and PMP contacts, professional societies, policy materials and monitoring references

Diversion prevention programs at real hospitals and health systems with a measured result, each linked to its source

Curated tools, templates, and reference materials for diversion prevention programs

Purpose, scope, and methodology behind the DivertGuard assessment tool

Author of DivertGuard — IHFDA Annual Conference presenter, ASHP Drug Diversion Certificate faculty, and HCCA speaker

How DivertGuard content is researched, reviewed, and kept current

Reference listing of diversion prevention technology vendors and professional associations by category

Real-world drug diversion events with analysis and prevention lessons

Short illustrative narratives of how diversion is discovered in a pharmacy or hospital: the first signal, the confirmation, and the control that would have caught it sooner. Composites, not real events

Filter all documented diversion cases by year, state, setting, drug, and prosecution status

Download every documented diversion case as CSV or JSON, with field definitions, sourcing and a citation

DEA 106 deadline calculator, controlled substance discrepancy calculator, and waste percentage calculator

Ask questions and share lessons learned on diversion prevention with peers

Conferences, training, and webinars for diversion prevention, pharmacy compliance, and regulatory professionals

Free assessments, case data, and playbooks for IHFDA members and attendees, from a 3-time IHFDA presenter